These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28956)

  • 41. Chronic proglumide increases [3H]spiperone binding in the rat brain.
    Bean AJ; Baldy WJ; Martin GE
    Eur J Pharmacol; 1985 Oct; 117(1):97-101. PubMed ID: 4085545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations.
    Theodorou AE; Hall MD; Jenner P; Marsden CD
    J Pharm Pharmacol; 1980 Jun; 32(6):441-4. PubMed ID: 6106685
    [No Abstract]   [Full Text] [Related]  

  • 44. Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration.
    Owen F; Cross AJ; Waddington JL; Poulter M; Gamble SJ; Crow TJ
    Life Sci; 1980 Jan; 26(1):55-9. PubMed ID: 7189005
    [No Abstract]   [Full Text] [Related]  

  • 45. Solubilization of 3H-spiperone binding sites from rat brain.
    Gorissen H; Laduron PM
    Life Sci; 1978 Aug; 23(6):575-9. PubMed ID: 692282
    [No Abstract]   [Full Text] [Related]  

  • 46. Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex.
    Howlett DR; Nahorski SR
    Life Sci; 1980 Feb; 26(7):511-7. PubMed ID: 7366332
    [No Abstract]   [Full Text] [Related]  

  • 47. Early supersensitive changes in [3H] spiroperidol binding in the isolated striatum.
    Csernansky JG; Friedhoff AJ; Bonnet KA
    Biochem Biophys Res Commun; 1982 Mar; 105(1):117-20. PubMed ID: 6124243
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats.
    Bhargava HN
    Eur J Pharmacol; 1984 Apr; 100(1):109-12. PubMed ID: 6723774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A partially rigid butyrophenone analog with extended conformation.
    Chan CC; Farmer PS
    Pharmazie; 1986 Dec; 41(12):835-6. PubMed ID: 2883672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postsynaptic location of acrylamide-induced modulation of striatal 3H-spiroperidol binding.
    Hong JS; Tilson HA; Agrawal AK; Karoum F; Bondy SC
    Neurotoxicology; 1982 Jul; 3(1):108-12. PubMed ID: 6890181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
    Thal LJ; Horowitz SG; Dvorkin B; Makman MH
    Brain Res; 1980 Jun; 192(1):185-94. PubMed ID: 7378779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 53. Ovine prolactin administration modifies [3H]spiperone binding to striatal membranes of rabbits.
    Eva C; Blengio M; Ferretti C; Muccioli G; Portaleone P
    Brain Res; 1982 Nov; 251(2):388-90. PubMed ID: 7139336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction of 3H-spiroperidol binding in rat striatum and frontal cortex by chronic amphetamine: dose response, time course and role of sustained dopamine release.
    Nielsen EB; Nielsen M; Braestrup C
    Psychopharmacology (Berl); 1983; 81(1):81-5. PubMed ID: 6415736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific [3H]-spiroperidol binding sites in human prefrontal cortex: potential site multiplicity and overall serotonin-like selectivity.
    Andorn AC; Huang EH; Warren AE
    Life Sci; 1984 Jun; 34(25):2461-6. PubMed ID: 6145080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain.
    Pedigo NW; Yamamura HI; Nelson DL
    J Neurochem; 1981 Jan; 36(1):220-6. PubMed ID: 7463047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
    Creese I; Snyder SH
    Eur J Pharmacol; 1979 Jun; 56(3):277-81. PubMed ID: 38973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors.
    Palacios JM; Niehoff DL; Kuhar MJ
    Brain Res; 1981 Jun; 213(2):277-89. PubMed ID: 7248759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.